New drug shows promise for hepatitis C
Nov. 5, 2008
Hepatitis C is a blood-borne infectious disease that is often without symptoms and can cause inflammation of the liver, cirrhosis, and in extreme cases, liver cancer. It is usually contracted through transfusions of unscreened blood, or by injecting or inhaling drugs. The high response rates seen with boceprevir in this study are very exciting, especially given that (the type of virus studied), genotype 1, is the most common and hardest to treat form of hepatitis C," said lead researcher Dr. Paul Kwo of the Indiana University School of Medicine in Indianapolis.
Read the entire story at: http://in.reuters.com/article/health/idINTRE4A38I120081104
Learn more about the Indiana University School of Medicine at: http://medicine.iu.edu/